UPDATED Jul 10, 2025
Discover Belgian Pharmaceuticals & Biotech Growth Stocks that are on the BEL20. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
HYL | €6.38 | 1.9% | -45.5% | €178.6m | €13.00 | PS18.3x | E60.0% | n/a | ||
ARGX | €485.40 | 5.4% | 12.9% | €29.7b | €664.70 | PE32.7x | E27.7% | n/a | ||
UCB | €172.60 | 5.5% | 19.4% | €32.8b | €212.29 | PE30.8x | E18.1% | 0.8% | ||
CYAD | €0.35 | -5.4% | 34.4% | €14.5m | n/a | PS78x | n/a | n/a | ||
ALEMS | €4.60 | 2.2% | -36.6% | €19.5m | n/a | PE35.7x | n/a | n/a | ||
OXUR | €0.027 | -12.9% | -97.3% | €335.6k | n/a | PE2.8x | n/a | n/a | ||
BIOS | €0.0024 | 4.3% | -82.1% | €1.6m | n/a | PE-0.2x | n/a | n/a | ||
TUB | €137.40 | 5.5% | 24.0% | €6.1b | €182.75 | PE67.9x | n/a | 0.8% |